Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy

Psoriatic patients with latent tuberculosis infection and properly treated active tuberculosis need careful management when prescribing modern biological drugs. Although data and guidelines regarding tumour necrosis factor-α inhibitors advise caution and initiation of prophylactic therapy in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: MASTORINO, Luca, DAPAVO, Paolo, TRUNFIO, Mattia, AVALLONE, Gianluca, RUBATTO, Marco, CALCAGNO, Andrea, RIBERO, Simone, QUAGLINO, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Publication of Acta Dermato-Venereologica 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811291/
https://www.ncbi.nlm.nih.gov/pubmed/36065745
http://dx.doi.org/10.2340/actadv.v102.1982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811291/
https://www.ncbi.nlm.nih.gov/pubmed/36065745
http://dx.doi.org/10.2340/actadv.v102.1982

Ejemplares similares